The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Pharmaceutical treatment of osteoarthritis
Open accessAbstract
OBJECTIVE To review the current state of pharmaceutical treatment recommendations for the management of osteoarthritis. METHOD A narrative review was drafted to describe treatment guidelines, mechanism of action, pharmacokinetics, and toxicity for nine classes of pharmaceuticals: 1) oral nonsteroidal anti-inflammatory drugs (NSAIDs), 2) topical NSAIDs, 3) COX-2 inhibitors, 4) duloxetine, 5) intra-articular corticosteroids, 6) intra-articular hyaluronic acid, 7) acetaminophen (paracetamol), 8) tramadol, and 9) capsaicin. RESULTS In general, oral and topical NSAIDs, including COX-2 inhibitors, are strongly recommended first-line treatments for osteoarthritis due to their ability to improve pain and function but are associated with increased risks in patients with certain comorbidities (e.g., heightened cardiovascular risks). Intra-articular corticosteroid injections are generally recommended for osteoarthritis management and have relatively minor adverse effects. Other treatments, such as capsaicin, tramadol, and acetaminophen, are more controversial, and many updated guidelines offer differing recommendations. CONCLUSION The pharmaceutical management of osteoarthritis is a constantly evolving field. Promising treatments are emerging, and medicines that were once considered conventional (e.g., acetaminophen) are gradually becoming less acceptable based on concerns with efficacy and safety. Clinicians need to consider the latest evidence and recommendations to make an informed decision with their patients about how to optimize treatment plans for patients with knee, hip, polyarticular, or hand osteoarthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis
Bannuru, R. R., Osani, M. C., Vaysbrot, E. E., Arden, N. K., Bennell, K., Bierma-Zeinstra, S. M. A., Kraus, V. B., Lohmander, L. S., Abbott, J. H., Bhandari, M., et al. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.06.011 · Cited by 3,542
Self-citationKolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., Egger, M., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.c7086 · Cited by 1,166
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
McAlindon, T. E., LaValley, M. P., Harvey, W. F., Price, L. L., Driban, J. B., Zhang, M., & Ward, R. J. (2017) · JAMA · doi:10.1001/jama.2017.5283 · Cited by 860
Self-citationHyaluronic Acid in the Third Millennium
Fallacara, A., Baldini, E., Manfredini, S., & Vertuani, S. (2018) · Polymers · doi:10.3390/polym10070701 · Cited by 860
Anti-inflammatory drugs and their mechanism of action
Vane, J. R., & Botting, R. M. (1998) · Inflammation Research · doi:10.1007/s000110050284 · Cited by 798
Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory
Gupta, R. C., Lall, R., Srivastava, A., & Sinha, A. (2019) · Frontiers in Veterinary Science · doi:10.3389/fvets.2019.00192 · Cited by 741
Viscosupplementation for Osteoarthritis of the Knee: A Systematic Review and Meta-analysis
Rutjes, A. W. S., Jüni, P., da Costa, B. R., Trelle, S., Nüesch, E., & Reichenbach, S. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-3-201208070-00473 · Cited by 717
Whelton, A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00113-8 · Cited by 704
Anand, P., & Bley, K. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer260 · Cited by 700
Bruyère, O., Honvo, G., Veronese, N., Arden, N. K., Branco, J., Curtis, E. M., Al-Daghri, N. M., Herrero-Beaumont, G., Martel-Pelletier, J., Pelletier, J.-P., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.04.008 · Cited by 695
Molecular mechanisms of glucocorticoid action: what is important?
Newton, R. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 510
Paracetamol (Acetaminophen): mechanisms of action
ANDERSON, B. J. (2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2008.02764.x · Cited by 497
Clinical Pharmacokinetics of Paracetamol
Forrest, J. A. H., Clements, J. A., & Prescott, L. F. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207020-00001 · Cited by 493
2018 update of the EULAR recommendations for the management of hand osteoarthritis
Kloppenburg, M., Kroon, F. P., Blanco, F. J., Doherty, M., Dziedzic, K. S., Greibrokk, E., Haugen, I. K., Herrero-Beaumont, G., Jonsson, H., Kjeken, I., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213826 · Cited by 489
Clinical Pharmacology of Corticosteroids
Williams, D. M. (2018) · Respiratory Care · doi:10.4187/respcare.06314 · Cited by 460
Ayhan, E. (2014) · World Journal of Orthopedics · doi:10.5312/wjo.v5.i3.351 · Cited by 441
(2014) · PubMed · Cited by 390
Cardiovascular effects and safety of (non-aspirin) NSAIDs
Schjerning, A.-M., McGettigan, P., & Gislason, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0366-z · Cited by 387
Mechanisms and clinical uses of capsaicin
Sharma, S. K., Vij, A. S., & Sharma, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.053 · Cited by 364
Cyclooxygenase Enzymes: Regulation and Function
Fitzpatrick, F. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453144 · Cited by 340
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Systemic effects of intra-articular corticosteroids
Habib, G. S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1135-x · Cited by 273
Dayer, P., Desmeules, J., & Collart, L. (1997) · Drugs · doi:10.2165/00003495-199700532-00006 · Cited by 269
Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis
Zeng, C., Dubreuil, M., LaRochelle, M. R., Lu, N., Wei, J., Choi, H. K., Lei, G., & Zhang, Y. (2019) · JAMA · doi:10.1001/jama.2019.1347 · Cited by 256
Cooper, C., Chapurlat, R., Al-Daghri, N., Herrero-Beaumont, G., Bruyère, O., Rannou, F., Roth, R., Uebelhart, D., & Reginster, J.-Y. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00660-1 · Cited by 248
Intra-articular targeting of nanomaterials for the treatment of osteoarthritis
Brown, S., Kumar, S., & Sharma, B. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.03.010 · Cited by 247
Duloxetine: Clinical Pharmacokinetics and Drug Interactions
Knadler, M. P., Lobo, E., Chappell, J., & Bergstrom, R. (2011) · Clinical Pharmacokinetics · doi:10.2165/11539240-000000000-00000 · Cited by 237
Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review
Kaye, A. D. (2015) · Pain Physician · doi:10.36076/ppj.2015/18/395 · Cited by 235
Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue
Varga, Z., Sabzwari, S. R. A., & Vargova, V. (2017) · Cureus · doi:10.7759/cureus.1144 · Cited by 231
Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs
Verbeeck, R. K., Blackburn, J. L., & Loewen, G. R. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308040-00003 · Cited by 224
Zeng, C., Wei, J., Persson, M. S. M., Sarmanova, A., Doherty, M., Xie, D., Wang, Y., Li, X., Li, J., Long, H., et al. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098043 · Cited by 223
Celecoxib pathways: pharmacokinetics and pharmacodynamics
Gong, L., Thorn, C. F., Bertagnolli, M. M., Grosser, T., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834f94cb · Cited by 205
Systemic Absorption and Side Effects of Locally Injected Glucocorticoids
Stout, A., Friedly, J., & Standaert, C. J. (2019) · PM&R · doi:10.1002/pmrj.12042 · Cited by 170
Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
Paik, J., Duggan, S. T., & Keam, S. J. (2019) · Drugs · doi:10.1007/s40265-019-01083-3 · Cited by 168
Kraus, V. B., Conaghan, P. G., Aazami, H. A., Mehra, P., Kivitz, A., Lufkin, J., Hauben, J., Johnson, J. R., & Bodick, N. C. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.10.003 · Cited by 159
Discovery and development of tramadol for the treatment of pain
Bravo, L., Mico, J. A., & Berrocoso, E. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1377697 · Cited by 158
Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers
Paulson, S. K., Hribar, J. D., Liu, N. W., Hajdu, E., Bible, R. H., Piergies, A. A., & Karim, A. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15366-4 · Cited by 157
Topical NSAID Therapy for Musculoskeletal Pain
Haroutiunian, S., Drennan, D. A., & Lipman, A. G. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00809.x · Cited by 149
Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?
Creamer, P. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.634 · Cited by 145
Balogh, L., Polyák, A., Máthé, D., Király, R., Thuróczy, J., Terez, M., Jánoki, G. A., Ting, Y., Bucci, L. R., & Schauss, A. G. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8017029 · Cited by 140
Makris, U. E., Kohler, M. J., & Fraenkel, L. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090935 · Cited by 122
Revisiting Tramadol: A Multi-Modal Agent for Pain Management
Barakat, A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00623-5 · Cited by 120
Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani, E. Z., & Islam, K. (2008) · PubMed · Cited by 116
Gong, L., Stamer, U. M., Tzvetkov, M. V., Altman, R. B., & Klein, T. E. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000057 · Cited by 113
Pergolizzi, J. V., Raffa, R. B., Taylor, R., Rodriguez, G., Nalamachu, S. R., & Langley, P. C. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00578.x · Cited by 111
Scott, P. A., Kingsley, G. H., Smith, C. M., Choy, E., & Scott, D. L. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068650 · Cited by 104
Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis
Osani, M. C., & Bannuru, R. R. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.460 · Cited by 91
Update on Cyclooxygenase-2 Inhibitors
Harris, R. C., & Breyer, M. D. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00890805 · Cited by 75
Comparison of tissue and plasma levels of ibuprofen after oral and topical administration.
Dominkus, M., Nicolakis, M., Kotz, R. I., Wilkinson, F. E., Kaiser, R., & Chlud, K. (1996) · PubMed · Cited by 63
Hummer, C. D., Angst, F., Ngai, W., Whittington, C. J., Yoon, S. S., Duarte, L., Manitt, C., & Schemitsch, E. H. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03729-w · Cited by 60
Wu, Y.-Z., Huang, H., Ho, C.-J., Shih, C., Chen, C., Cheng, T., Wang, Y., & Lin, S.-Y. (2021) · Cartilage · doi:10.1177/19476035211021903 · Cited by 59
Bahrami, M. H., Raeissadat, S. A., Cheraghi, M., Dehgolan, S. R., & Ebrahimpour, A. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03577-8 · Cited by 48
Gigis, I., Fotiadis, E., Nenopoulos, A., Tsitas, K., & Hatzokos, I. (2016) · PubMed Central · Cited by 37
Duloxetine, an antidepressant with analgesic properties - a preliminary analysis.
Onuțu, A. H. (2015) · PubMed · Cited by 35
Zilva, J. F. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.9.907-e · Cited by 31
Effect of Lipophilicity on in Vivo Iontophoretic Delivery. I. NSAIDs.
Tashiro, Y., Shichibe, S., Kato, Y., Hayakawa, E., & Kunio, I. T. O. H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.278 · Cited by 29
NSAID Single-Drug–Induced Reactions
Woessner, K. M., & Castells, M. (2013) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2012.12.002 · Cited by 29
Li, L., Marozoff, S., Lu, N., Xie, H. W., Kopec, J. A., Cibere, J., Esdaile, J. M., & Aviña-Zubieta, J. A. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02764-3 · Cited by 19
Pharmacokinetics and Pharmacodynamics of Hyaluronan Infused into Healthy Human Volunteers
Hamilton, S. R., Veiseh, M., Tölg, C., Tirona, R. G., Richardson, J., Brown, R., Ángel-González, M., Vanzieleghem, M. A., Anderson, P. S., Asculai, S. S., et al. (2009) · The Open Drug Metabolism Journal · doi:10.2174/1874073100903010043 · Cited by 16
Cited by
Arachidonic acid metabolism in health and disease
Zhang, Y., Liu, Y., Sun, J., Zhang, W., Guo, Z., & Ma, Q. (2023) · MedComm · doi:10.1002/mco2.363 · Cited by 295
Hyaluronic Acid: A Powerful Biomolecule with Wide-Ranging Applications—A Comprehensive Review
Iaconisi, G. N., Lunetti, P., Gallo, N., Cappello, A. R., Fiermonte, G., Dolce, V., & Capobianco, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210296 · Cited by 258
Bi, J., Zhang, L., Zhang, P., Xu, S., Liu, Y., Zhang, X., Qiu, X., Bi, Y., Yan, F., Wei, H., et al. (2024) · Biomaterials Research · doi:10.34133/bmr.0075 · Cited by 12
The Potential of Intra-Articular Therapies in Managing Knee Osteoarthritis: A Systematic Review
Pojala, C. V., Toma, S., Costache, C., Peter, T., Pojala, C. E., Roman, N. A., & Dima, L. (2024) · Clinics and Practice · doi:10.3390/clinpract14050157 · Cited by 10
“Additionally, oral NSAIDs, intra-articular (IA) corticosteroids, and hyaluronan are strongly recommended for individuals with knee osteoarthritis, with treatment options tailored to the specific type of OA [36,37].”
Background
Metadata
- Authors
- Richard, M. J., Driban, J. B., & McAlindon, T. E.
- Venue
- Osteoarthritis and Cartilage
- Publisher
- Elsevier BV
- Published
- 2023-04
- Volume
- 31
- Issue
- 4
- Pages
- 458-466
- ISSN
- 1063-4584 (ISSN-L)
- OpenAlex
- W4309567156
- Cited by
- 324
- References
- 61
- FWCI
- 33.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.